AU:RAC Stock Latest News
Company AnnouncementsRacura Presents Preclinical Data on Active Bisantrene Isomer6h agoRAC
Company AnnouncementsRacura Oncology Sets Date and Venue for 2026 In-Person AGM3w agoRAC
Company AnnouncementsRacura Oncology strengthens RC220 clinical pipeline on solid cash base3w agoRAC
Company AnnouncementsRacura Oncology Cleared to Escalate RC220 Dose in HARNESS-1 Trial1M agoRAC
Company AnnouncementsRacura Oncology Sets AGM Date and Deadline for Director Nominations1M agoRAC
Company AnnouncementsRace Oncology director Daniel Tillett lifts indirect shareholding1M agoRACCompany AnnouncementsRacura Oncology CEO Restructures Shareholdings With No Change in Overall Stake1M agoRAC
Company AnnouncementsRacura Oncology Data Boosts MYC-Targeted Cancer Program and IP Position2M agoRAC
Company AnnouncementsRacura Oncology to Host Adelaide Investor Briefing on Clinical Pipeline2M agoRAC
Company AnnouncementsRacura Oncology Issues New Long-Dated Employee Options2M agoRAC
Company AnnouncementsRacura Oncology Opens Korean Sites for RC220 Cardioprotective Cancer Trial2M agoRAC
Company AnnouncementsRacura Oncology details strengthened corporate governance framework2M agoRAC
Company AnnouncementsRace Oncology lodges ASX corporate governance statement for FY262M agoRACCompany AnnouncementsRacura Oncology CEO to Spotlight Phase 3 Cancer Programs at TechKnow Invest Conference3M agoRAC
Company AnnouncementsRacura Advances HARNESS-1 Trial After Safe First-Patient Treatment With RC220 Combo3M agoRAC
Company AnnouncementsRace Oncology Options Expire, Slightly Tightening Capital Structure4M agoRAC
Company AnnouncementsRacura to Present RC220 Cardio-Oncology Phase 1 Data at 2026 Global Summit4M agoRAC
Company AnnouncementsRacura Oncology to Spotlight RC220 Pipeline at New Zealand Investor Events4M agoRAC
Company AnnouncementsRacura Oncology gains ethics approval to expand HARNESS-1 lung cancer trial4M agoRAC


